| Financial Year |
March 31 2023 |
| Monetary Funds |
14,233,591,218.09 |
| Held-for-trading Financial Assets |
1,744,251,394.69 |
| Notes Receivable |
387,698,014.26 |
| Accounts Receivable |
5,708,771,518.66 |
| Advances to Suppliers |
1,049,592,143.21 |
| Other Receivables |
596,674,132.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,542,697,936.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
520,974,218.11 |
| Total Current Assets |
30,650,444,105.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
767,861,518.38 |
| Investment Properties |
-- |
| Fixed Assetes |
5,343,629,982.58 |
| Under-construction Projects |
1,219,912,127.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
596,559,199.76 |
| R&D expenses |
1,878,178,269.49 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
353,362,266.07 |
| Deferred Income Tax Assets |
224,678,861.67 |
| Other Non-Current Assets |
431,429,354.37 |
| Sub-Total of Non-Current Assets |
11,643,385,891.08 |
| Total Assets |
42,293,829,996.23 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
203,506,589.39 |
| Accounts Payable |
1,680,197,323.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
673,367.54 |
| Taxes Payable |
182,378,759.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
249,638,644.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
10,572,475.62 |
| Sub-Total of Current Liabilities |
2,536,712,807.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
78,778,760.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
283,033,133.82 |
| Total Liabilities |
2,819,745,940.98 |
| Paid-In Capital(Or Share Stock) |
6,379,002,274.00 |
| Capital Surplus |
3,069,987,488.76 |
| Surplus Reserve |
3,298,912,011.55 |
| LESS:Treasury Stock |
600,555,670.59 |
| Undistributed Profits |
26,759,562,705.04 |
| Minority Stockholder's Interest |
582,273,950.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
38,891,810,104.97 |
| Owner's Equity（Stockholder's Equity） |
39,474,084,055.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,293,829,996.23 |
